MARKETSHorizon Pharma Stock Goes Vertical After Positive Eye Disease Drug ResultsBy Scott Van VoorhisFeb 28, 2019 11:10 AM EST
PRESS RELEASESHorizon Therapeutics Plc Announces U.S. FDA Approval Of New Dosage Form For PROCYSBI® (Cysteamine Bitartrate) Delayed-Release Oral GranulesBy Business WireFeb 18, 2020 8:00 AM EST
PRESS RELEASESUplifting Athletes Announces Horizon Therapeutics Plc As Exclusive Sponsor To Help Tackle Rare Disease At The National Football League (NFL) Scouting CombineBy Business WireFeb 11, 2020 8:00 AM EST
PRESS RELEASESHorizon Therapeutics Plc To Release Fourth-Quarter And Full-Year 2019 Financial Results And Host Webcast On Feb. 26, 2020By Business WireFeb 4, 2020 8:00 AM EST
PRESS RELEASESHorizon Therapeutics Announces Significant Expansion And Relocation Of U.S. OperationsBy Business WireJan 28, 2020 11:10 AM EST
PRESS RELEASESHorizon Therapeutics Plc Announces Changes In Research And Development OrganizationBy Business WireJan 24, 2020 4:05 PM EST
PRESS RELEASESThe New England Journal Of Medicine Publishes Comprehensive Data From Phase 3 Clinical Trial (OPTIC) Of TEPEZZA™ (teprotumumab-trbw) For Thyroid Eye DiseaseBy Business WireJan 22, 2020 5:20 PM EST
PRESS RELEASESFDA Approves TEPEZZATM (teprotumumab-trbw) For The Treatment Of Thyroid Eye Disease (TED)By Business WireJan 21, 2020 3:04 PM EST
PRESS RELEASESHorizon Therapeutics Plc Increases Peak U.S. Annual Net Sales Expectations For Key Growth Drivers; Provides Update On Several Pipeline ProgramsBy Business WireJan 13, 2020 8:15 AM EST
PRESS RELEASESMIRROR Open-Label Study Topline Data Of Methotrexate With KRYSTEXXA (pegloticase Injection) Indicates Significant Improvement In Response RateBy Business WireJan 13, 2020 8:05 AM EST
MARKETSHorizon Pharma Stock Goes Vertical After Positive Eye Disease Drug ResultsBy Scott Van VoorhisFeb 28, 2019 11:10 AM EST
JIM CRAMERPepsiCo, Ford Motor, Teladoc: 'Mad Money' Lightning RoundBy Scott RuttJan 30, 2019 8:11 PM EST
REGULATIONWhy investors shouldn't worry about Trump's tough talk on drug pricesBy Bill MeagherFeb 8, 2018 9:09 AM EST
FUTURESDow Scores Ninth Straight Record Close With Tiny GainsBy Keris Alison LahiffAug 7, 2017 8:10 PM EDT
FUTURESDow Is Back on Track to Close at a Record High as Consumer Staples LeadBy Keris Alison LahiffAug 7, 2017 3:10 PM EDT
FUTURESEnergy Losses Put Dow's Record-Breaking Streak in JeopardyBy Keris Alison LahiffAug 7, 2017 10:41 AM EDT
HEALTHBiotech Movers: Second Quarter Results, Increased Outlook Send Horizon Pharma Shares HigherBy Armie Margaret LeeAug 7, 2017 9:27 AM EDT
FUTURESStock Futures Rise as Dow Shoots for Its Ninth Straight Day of RecordsBy Keris Alison LahiffAug 7, 2017 8:39 AM EDT
VIDEOClosing Bell: Volatility at Lowest Since 1993; Pershing Backs Howard HughesBy Keris Alison LahiffMay 8, 2017 4:37 PM EDT
FUTURESStocks Tread Water as Volatility Reaches Lowest Level in 24 YearsBy Keris Alison LahiffMay 8, 2017 4:07 PM EDT
FUTURESStocks Lower Again in 'Comfortably Numb' Trading, Volatility at 24-Year LowBy Keris Alison LahiffMay 8, 2017 2:57 PM EDT
FUTURESStocks Creep Lower in 'Comfortably Numb' Trading After French ElectionBy Keris Alison LahiffMay 8, 2017 11:20 AM EDT
